chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt A and O x3. HPV given L deltoid. Pt passed out 1-2 secs after vaccine given. Pt arousable. A and O x 3. Vital signs stable. Pt tearful and pale. Pt states she had not eaten or drank anything. Pt given 8 oz apple juice.
Extremely sharp heart t and chest pain - lasted 30 minutes about 4-5 hours after first dose
Developed tachycardia March 2021, developed Ig-A vasculitis September and October 2021, developed Atrial fibrillation November 2021, ILD December 2021, developed hypoxemia March 3022, developed pulmonary hypertension May 2022, developed pericarditis and restrictive pericarditis June 2022, developed heart failure and diastolic heart failure August 2022.
I have been having menstrual cramps ever since my second dose. I did not have a period for the month of August. I am still having painful menstrual cramps almost every day. I did some research and found that other women are having these problem as well.
This spontaneous report has been received from a pharmacist refers to a 64 years old female patient with versed allergy and unspecified pertinent medical history who was vaccinated SC on the left arm with a 0.65 ml dose of ZOSTAVAX (lot # 672612/1653AA: Exp Date 21-JAN-2013) on 25-JUL-2012. There were some unspecified concomitant medications. On 25-JUlL-2012 the reporter stated that the patient had a monetary feeling of heaviness in her chest, a slight headache and a metallic taste in her mouth just after being vaccinated ZOSTAVAX. The pharmacist stated that they monitored the patient at the pharmacy for at least 18 minutes post vaccination. No treatment was given. Pharmacist stated that the patient told her she felt okay now. Additional information has been requested.
Area around the vax site was red, indurated and vesicular. The child was started on Benadryl and Duricet for 10 days.
Redness, itchiness, ?lump? in the injection site measuring 5cm in diameter after s/p day 1 of injection, went away after 2-3days from injection date.   Fatigue, sinus-infection like symptoms after 6days from injection date.  Reoccurrence after 7days from injection date of cutaneous reaction: redness, itchiness, bruising, ?lump? in the injection site measuring 6-7cm in diameter. Warm to touch.
Patient complained of right arm pain that was stabbing and keeping her up all night. She stated that the pain had been going on for a week. We told her to inform her doctor of the issue.
feeling off; Fatigue; Some body aches.; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization completed. Unknown manufacturer, Dose 2), for COVID-19 immunization; Covid-19 vaccine (DOSE 3), for COVID-19 immunization; Covid-19 vaccine (Primary immunization completed. Unknown manufacturer, Dose 1), for COVID-19 immunization. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "feeling off"; FATIGUE (non-serious), outcome "unknown"; PAIN (non-serious), outcome "unknown", described as "Some body aches.".  Additional information: It was reported that had side effects from COVID vaccine. The patient had the original two plus two boosters. Day or two, feeling off, fatigue, some body aches. States is, that normal. That's your immune system just ramping.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
flu like symptoms; body aches; tiredness; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dose in August 2019, refer case US2020AMR003738.).   On 4th January 2020, the patient received the 2nd dose of Shingrix. On 4th January 2020, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms, general body pain and tiredness. On 5th January 2020, the outcome of the influenza-like symptoms, general body pain and tiredness were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, general body pain and tiredness to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix and had influenza-like symptoms, general body pain and tiredness. The reporter did not consent to follow up. This case linked US2020AMR003672 and US2020003251, reported by same reporter.
PATIENTR REPORTS SEVERE ITCHING ON LEFT ARM. ITCH HAS TRAVELED TO CHEST.
TREMENDOUS HEADACHE LIKE MIGRAINE; MILD PAIN IN THE INJECTION SITE; MILD ALLERGY; TIGHTNESS OF CHEST; FLU LIKE SYMPTOMS; THROAT FELT FUNNY; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy to dust, and acid reflux. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-APR-2021, the subject experienced tightness of chest. On 08-APR-2021, the subject experienced flu like symptoms. On 08-APR-2021, the subject experienced throat felt funny. On 08-APR-2021, the subject experienced mild pain in the injection site. On 08-APR-2021, the subject experienced mild allergy. Laboratory data included: Body temperature (NR: not provided) 102.5 F. On 09-APR-2021 03:00, the subject experienced tremendous headache like migraine. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tightness of chest, throat felt funny, tremendous headache like migraine, mild pain in the injection site, and mild allergy on APR-2021, and flu like symptoms on 2021. This report was non-serious.
Tinnitus; This case was reported by a consumer via sales rep and described the occurrence of tinnitus in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced tinnitus. On an unknown date, the outcome of the tinnitus was unknown.   It was unknown if the reporter considered the tinnitus to be related to Shingrix.     Additional Information: GSK Receipt Date: 04-July-2022 Reporter's comment: The reporter was an employee. The reporter was patient itself. The patient received Shingrix on an unknown date and experienced tinnitus. The reporter agrees to follow up from GlaxoSmithKline.
pt recv vax 13JUN95 & 16JUN seen by MD for a sever inj site rxn;dx cellulitis & tx w/Keflex;MD visit on 19JUN95-rxn appeared to be resolving;no skin cult done;
Redness, warmth, swelling and tenderness at site of Pneumovax injection.
The pt experienced redness, swelling to the left thigh, possible cellulitis. Treated with Benadryl and Cefzil.
This spontaneous report as received from a physician via an unspecified reporter through a company representative, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 23-JUL-2015, the patient was vaccinated with VAQTA "25U/.5ML 10x1(ped), lot # J000985 with expiration date 20-AUG-2015 (route of administration unknown), which was stored at -1 Celsius Degrees for 24 hours, at 0 Celsius Degrees for 48 hours, at 1 Celsius Degrees for 48 hours and at 9 Celsius Degrees for 72 hours. The storage criteria and the type of excursion was refrigerator (R) and the vaccine status was reported as "in excursion". There were no concomitant therapies and adverse effects reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Stroke - right facial paralysis, speech slurring,  Numbness on right side, unsteady walking hospitalization - CT, Holter monitor for one month,  vascular appt, PT/OT, speech therapy Ongoing
I experienced severe shortness of breath, extremely high blood pressure, severe chest pain.  As I read the myocarditis symptoms people were experiencing it seemed like I was having the same issues.  Went to urgent care and there was discussion of side effect of vaccine but not very serious.  I had a similar less extreme side effect from the first dose, no side effect from the second dose, but booster was more serious.
Lymph nodes in left armpit swollen to size of softball; This is a spontaneous report from a contactable other HCP (patient).   A 30-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm left on 05Sep2021 10:00 (at the age of 30-year-old) (Batch/Lot number was not reported) as single dose, dose 2 via an unspecified route of administration, administered in arm left on 05Sep2021 10:00 (at the age of 30-year-old) (Batch/Lot number was not reported) as single dose, for COVID-19 immunisation (as reported). Medical history was none. No known allergies. The patient's concomitant medications were not reported. No other vaccine in fourweeks. No other medications in twoweeks. No patient drug events. The patient was not pregnant. Patient had not COVID prior vaccination. The patient experienced lymph nodes in left armpit swollen to size of softball (medically significant) on 06Sep2021 12:00 AM with outcome of not recovered. No treatment received. COVID was not tested post vaccination.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the event cannot be completely excluded.
Info. has been received from an MD concerning a 39 y.o. female dental office secretary who was vax'd w/a "series" of Hep B vax recombinant in the "early" 80's. Subsequently, the PT had a "titer" done and had "no titer". Subsequently, the PT was vax'd w/the first dose of her 2nd series of Hep B vax recombinant, and experienced SOB, nervousness, lethargy and tingling from the top of her head to her knees. Add'l info. has been requested.
sore arm at the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm at the injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm at the injection). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
This case was reported by a physician via other manufacturer and described the occurrence of allergic reaction in a 50-year-old female patient who received FLUARIX. On an unknown date, the patient received FLUARIX at an unknown dose. On an unknown date, an unknown time after receiving FLUARIX, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to FLUARIX.
Area of Men B vaccination on RT deltoid slightly erythematous and swollen (indurated) and tender. 6 x 7 cm induration.
headache; tingling in hand; swelling of face; feeling of shortness of breath; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of HEADACHE (headache), PARAESTHESIA (tingling in hand), SWELLING FACE (swelling of face) and DYSPNOEA (feeling of shortness of breath) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0237L20A) for COVID-19 vaccination.     Concurrent medical conditions included IgG decreased.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HEADACHE (headache), PARAESTHESIA (tingling in hand), SWELLING FACE (swelling of face) and DYSPNOEA (feeling of shortness of breath). At the time of the report, HEADACHE (headache), PARAESTHESIA (tingling in hand), SWELLING FACE (swelling of face) and DYSPNOEA (feeling of shortness of breath) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included, benadryl and injection epi pen. No concomitant medications were provided by reporter.
PATIENT STATED THAT ABOUT 6 HOURS AFTER VACCINE SHE BEGAN TO HAVE BUMPS WHICH THEN TURNED INTO A RASH IN THE ARMS AND THE TORSO, AS WELL AS THE LEGS. THE RASH HAS SPREAD IN THE BODY AND THERE IS SWELLING IN THE BOTH HANDS PRESENT. PATIENT STATED HER RASH IS ITCHING
Moderna COVID-19 Vaccine EUA   Lots of pain and soreness in vaccination site. Low fever(99.9F), chills, body ache, joint paint started 01/02/2021 at 4:30pm Treatment: slept and took 2 Tylenol?s.  Outcome: fever down to 99.2 an hour later, body still aching
Within 24 hours, large swelling, redness and tender at site of DTAP. Some fever that subsided in 2-3 days.
This spontaneous report was received from a registered nurse and refers to a 25 years old patient of unkown gender. No medical history, concurrent conditions or concomitant therapies were provided. On 20-JUL-2015, the patient was vaccinated wiht an improperly stored dose of VARIVAX (Merck) lot # J012377, expiration date 03-OCT-2015 (dose, route of administration and anatomical location were not reported). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
It was reported that a pt received a Menomune A/C/Y/W-135 vaccination and sometime, post vax, the pt developed a headache, fever and possible viral symptoms. Additional information is being requested. From correspondence received, it was reported on 3/25/00, the pt developed a fever (100F-101F), chills and pain in the head. Pt went to the ER at 19:30. A fever of 99F persisted until 3/29/00. The pt reportedly, recovered from this experience. Doctor dx'd idiosyncratic reaction to vaccine or an "exagena normal response" and nothing to be concerned about.
erythematous rash and swelling 17 X 1 cm left antero lateral thigh.
About 1 month after shot, started having sharp pains in balls of feet and toes, week later, couldn't swallow saliva. I could swallow food and drink, just not saliva by itself without gagging.  A week later, having a hard time breathing. Very fatigued and week.
Generalized itching, reddened skin, flat rash; areas on chest and neck- large (5 inches diameter) and red. Patient took 25mg Benadryl per her request. 1500 redness and itching subsiding, not completely gone. Took 25mg Benadryl at home in a.m.
Patient was unresponsive at home and taken to ER, labs and x-rays done in the ER, patient was admitted to hospital for observation and discharged the following day.
My arm became very sore about 20 minutes after the vaccination, and continued to become more sore and painful. I woke at about 3 am the morning after the vaccination with flu symptoms, very similar to a those in a 3-week illness from last March, 2020. Sinus pain and pressure, low fever, muscle aches, weakness. I was the same later that day, the and continued to have a low fever. By the next day those symptoms were gone, but I felt weak and very fatigued, chilled, and slept much of the day. The symptoms of extreme fatigue, feeling chilled, continued until late on Friday evening, the 19th. I am normally a very active person, but the fatigue was frightening, and not something I normally suffer from. From about 2pm on each day after being vaccinated, my energy plummeted, and the extreme fatigue set in and I slept all afternoon each day and then all night, each day feeling okay in the mornings, then boom, extreme fatigue beginning around 2 pm. I have only experience this kind of fatigue once when I had the flu many years ago, and also last March when my doc thought I had Covid, sent me to the emergency room to be tested, but at that time, they were only testing people who had just returned from China. I want to stress, I am rarely ill, I am very active, and to date am on no medications except vitamins. But last March I was very ill for three weeks then about three more weeks were needed for recovery.  My symptoms from this second vaccination have subsided, but with a small amount of fatigue remaining in the afternoons. So, I wonder, from the studies coming out, that I may have indeed had Covid last March, and my immune reaction to the second vaccine was extremely strong. And, possibly I only needed the first vaccination. I filed a Vaers report on my symptoms after the first vaccination, that were also strong, including Covid arm, but subsided about 5 days after that vaccination, a month earlier.
5JUN91 PC from mom stating pt was OK 3JUN91 day of shot just cranky, next day SOB, body jerky, 5JUN91 running fever 100, 102, 103; Seen by MD said could find no problems poss rxn to DTP; Given DT in future;
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 03-SEP-2015, the patient was vaccinated inadvertently with one dose of expired GARDASIL (lot # H020002, expiry date 08-AUG-2015, route was not reported). Concomitant medications were not reported. No adverse effects were reported. Additional information has been requested.
6 MONTH OLD MALE RECEIVED PFIZER COVID-19 VACCINE ORANGE CAP 0.2ML
Nauseousness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in Oct2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: Mar2022, for COVID-19 immunisation; Bnt162b2 (DOSE 2 , SINGLE), administration date: Apr2022, for COVID-19 immunisation; Bnt162b2;bnt162b2 omi ba.4-5 (DOSE 3 (BOOSTER), SINGLE), administration date: Dec2022, for COVID-19 immunisation. The following information was reported: NAUSEA (non-serious) with onset Oct2023, outcome "unknown", described as "Nauseousness".  Additional information: A female patient was asking if nausea was one of the side effects of Pfizer Covid vaccine. Said she got it about a week ago, her doctor seems concerned. Said does not mind the fever and the chills but she had nauseousness for about 10 hours afterwards. But last year it was not bad and does not remember having a nauseousness like this. Stated that she had the original two of Pfizer and the booster from the previous years. She got the original 2 series March or April and then got a booster in December that was bad, and this year was bad. Does not remember having side effects last year. This year that she got the nauseousness for 10 hours. And so, she gets nervous every time she had to take it because she does not want to feel that nauseousness again. And also wanted to confirm if it was for all of them or just for this year.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Patient developed pain at the injection site,  shortly after the vaccination, intensity 5/10, worse than the achiness following  her first COVID vaccine dose.  Also c/o palpitations, dizziness, and up-trending HTN, from 150/98 (HR 92) to 165/100 (HR 86). Transferred to  ER for further monitoring.
blurred vision; pain radiating in her neck for 24 hours; Felt foggy and had to lay down for 24 hours; injection site pain in her left arm; sharp pain in her lungs; her heart started racing; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (sharp pain in her lungs), PALPITATIONS (her heart started racing), VISION BLURRED (blurred vision), NECK PAIN (pain radiating in her neck for 24 hours) and FEELING ABNORMAL (Felt foggy and had to lay down for 24 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PULMONARY PAIN (sharp pain in her lungs), PALPITATIONS (her heart started racing), NECK PAIN (pain radiating in her neck for 24 hours), FEELING ABNORMAL (Felt foggy and had to lay down for 24 hours) and INJECTION SITE PAIN (injection site pain in her left arm). On 09-Mar-2021, the patient experienced VISION BLURRED (blurred vision). On 07-Mar-2021, PULMONARY PAIN (sharp pain in her lungs) and PALPITATIONS (her heart started racing) had resolved. On 08-Mar-2021, NECK PAIN (pain radiating in her neck for 24 hours), FEELING ABNORMAL (Felt foggy and had to lay down for 24 hours) and INJECTION SITE PAIN (injection site pain in her left arm) had resolved. On 09-Mar-2021, VISION BLURRED (blurred vision) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment medication was not provided.
Systemic: Pressure in ears-Severe, Systemic: Headache-Mild, Systemic: Hypertension-Severe, Systemic: Tinnitus-Severe, Additional Details: After receiving Prevnar 20 and Boostrix immunizations, the patient started to experience a lot of pressure in one side of her ear and some tinnitus.  Her blood pressure shot up as well.  She ended up having to go to the emergency.  She is feeling better now but still has some pressure in ear.  She is seeing her PCP on Monday.